SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Protein ‘Switch’ Suppresses Skin Cancer Development, University of Texas MD Anderson Cancer Center Study
September 10, 2008
 · 
1 min read
Lone Star Bio
Blood Pressure Treatment Can Be Used Against Stroke; University of Texas Medical School Study Finds The Therapy Can Be Given In Tandem With Clot-Dissolving Drug
September 10, 2008
 · 
1 min read
Drug Development
Change In HER2 Status Found After Treating Breast Cancer Patients With Herceptin, University of Texas MD Anderson Cancer Center Study
September 8, 2008
 · 
1 min read
Lone Star Bio
Infectious, Test Tube-Produced Prions Can Jump The ‘Species Barrier’ -- University of Texas Study
September 5, 2008
 · 
1 min read
Drug Development
Antidepressants Need New Nerve Cells To Be Effective, University of Texas Southwestern Medical Center Researchers Find
August 29, 2008
 · 
1 min read
Lone Star Bio
Laser Microscalpel to Target Cancers Individually, University of Texas Study
August 29, 2008
 · 
1 min read
Lone Star Bio
Gout Drug Cuts Teen High Blood Pressure; Allopurinol Lowers Teen Blood Pressure but Isn’t the Ultimate Answer, Baylor College of Medicine Researcher Says
August 27, 2008
 · 
1 min read
Lone Star Bio
Rutgers University and University of Texas Researchers Determine 3-D Structure Of A Key Site On A Flu Protein That Suppresses Human Defenses To Infection
August 26, 2008
 · 
1 min read
Lone Star Bio
Novel Drug Delivery Systems to Treat Mild Traumatic Brain Injury Based on Carbon Nanotubes, University of Texas Health Science Center, University of Texas Medical Branch, Baylor College of Medicine, Rice University and Transitional Learning Center
August 25, 2008
 · 
1 min read
Lone Star Bio
Molecule That Keeps Pathogens Like Salmonella In Check Uncovered, University of Texas Southwestern Medical Center Study; New Antibiotic May Block Toxins From Bacteria
August 22, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
CrossBridge Bio Awarded $15 Million CPRIT Grant to Advance CBB-120, Its Lead Dual-Payload ADC Targeting TROP-2, Into the Clinic
November 21, 2025
 · 
2 min read
Press Releases
Paradromics Receives FDA Approval for the Connect-One Clinical Study with the Connexus® Brain-Computer Interface
November 21, 2025
 · 
4 min read
Press Releases
Tekton Research Adds Two New Sites to Expand Neuroscience and General Medicine Capabilities in Key U.S. Markets
November 21, 2025
 · 
3 min read
Press Releases
FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
November 21, 2025
 · 
5 min read
Press Releases
Former US Congressman Dr. Brad Wenstrup Joins Maxwell Board
November 20, 2025
 · 
3 min read
Press Releases
FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2025
 · 
6 min read
Press Releases
Dialectic Therapeutics Announces Dosing of First Patient in Platinum-Resistant Ovarian Cancer (PROC)
November 20, 2025
 · 
4 min read
Press Releases
Cellipont Bioservices and Ronawk Partner to Advance Scalable Expansion of High-Quality Mesenchymal Stem Cells and Biologics
November 20, 2025
 · 
3 min read
Press Releases
EMILY SEDGWICK, M.D., NAMED CHIEF MEDICAL OFFICER OF SOLIS MAMMOGRAPHY
November 20, 2025
 · 
3 min read
Press Releases
FibroBiologics Announces Pricing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 20, 2025
 · 
6 min read
Load More